The Future of Body Composition Testing

Dr. Jeroen Molinger is Lead Clinical Medical Exercise Physiologist for the Duke Human Physiology and Pharmacology Lab; Program Director and Lead Senior Clinical Medical Exercise Physiologist for the Duke Heart, Cathlab, Cardiology Transplant, and Advanced Heart Failure Group; Program Director and Lead Senior Clinical Medical Exercise Physiologist for the Department of Anesthesiology, Duke Human Pharmacology and Physiology Laboratory; and the Operational and Program Director of the Duke LEEP-COVID Research Taskforce at Duke University Medical Center in Durham, North Carolina. He has a master’s degree in clinical exercise physiology from Maastricht University in the Netherlands and a master’s degree in advanced studies manual therapy from SOMT University in Amersfoort, the Netherlands; he is currently a PhD candidate and research associate at both Duke University Medical Center and Erasmus University Medical Center in Rotterdam, the Netherlands. His PhD focus is on longitudinal energy expenditure and systemic cardiopulmonary, metabolic, and mitochondrial changes of the phenotype during and after COVID-19 infection. In his various positions at Duke University, he focuses on the study of (pre)hospital-based treatments to improve preparation and recovery from major elective surgery, major illness, bone marrow transplant, chemotherapy and critical care across the aging spectrum; autonomic dysfunction in advanced heart failure; and evaluation of longitudinal cardiometabolic pathophysiology in patients with COVID-19 (LEEP-COVID) to understand, guide, and optimize the cardiometabolic care of these high-risk patients